Ikarian Capital »

Inmed Pharmaceuticals shares owned by Ikarian Capital

Quarter-by-quarter ownership of Inmed Pharmaceuticals (INM) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Inmed Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Inmed Pharmaceuticals held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inmed Pharmaceuticals by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $380k 245k 1.55

More positions owned by Ikarian Capital

Abivax Sa Sponsored Ads (ABVX)
Ionis Pharmaceuticals Call Option (IONS)
Kodiak Sciences (KOD)
Spdr Series Trust St Str Sp Biot Put Option (XBI)
Alumis (ALMS)
Praxis Precision Medicines I Com New (PRAX)
Moderna Put Option (MRNA)
Capricor Therapeutics Com New (CAPR)
Vaxcyte (PCVX)
Biosante Pharmaceuticals (ANIP)
Celldex Therapeutics Com New (CLDX)
Tenax Therapeutics Com New (TENX)
Vera Therapeutics Cl A (VERA)
Arcus Biosciences Incorporated (RCUS)
Relmada Therapeutics (RLMD)

View all positions for Ikarian Capital

Top funds holding Inmed Pharmaceuticals

ADAR1 Capital Management
Vivo Capital
Squadron Capital Management
Ikarian Capital
Ursa Fund Management
Suvretta Capital Management
Boothbay Fund Management
Sabby Management
Jane Street
VR Adviser
Citadel Advisors
Seven Grand Managers
Scientech Research
Crestwood Advisors
Two Sigma Securities

View all funds holding Inmed Pharmaceuticals